Utility of suPAR and NGAL for AKI Risk Stratification and Early Optimization of Renal Risk Medications among Older Patients in the Emergency Department

Utility of suPAR and NGAL for AKI Risk Stratification and Early Optimization of Renal Risk Medications among Older Patients in the Emergency Department

Diagnosis of acute kidney injury (AKI) based on plasma creatinine often lags behind actual changes in renal function. Here, we investigated early detection of AKI using the plasma soluble urokinase plasminogen activator receptor (suPAR) and neutrophil gelatinase-sssociated lipocalin (NGAL) and obser...

Full description

Bibliographic Details
Main Authors: Anne Byriel Walls, Anne Kathrine Bengaard, Esben Iversen, Camilla Ngoc Nguyen, Thomas Kallemose, Helle Gybel Juul-Larsen, Baker Nawfal Jawad, Mads Hornum, Ove Andersen, Jesper Eugen-Olsen, Morten Baltzer Houlind
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Pharmaceuticals
Subjects:
acute kidney injury
early biomarker
plasma neutrophil gelatinase-associated lipocalin
soluble urokinase plasminogen activator receptor
medication optimization
older patients
Online Access:https://www.mdpi.com/1424-8247/14/9/843

Internet

https://www.mdpi.com/1424-8247/14/9/843

Similar Items